Exposure to Anti-TNF Medications Does Not Increase the Risk of Cardiac Arrhythmia in Inflammatory Bowel Disease: A Population-Based Cohort Study

• L. Larsen,
• K.D. Olsen,
• H.S. Christensen,
• K.H. Allin,
• T. Jess

Affiliations

L. Larsen

Department of Clinical Medicine, Center for Molecular Prediction of Inflammatory Bowel Disease (PREDICT), Aalborg University, Copenhagen, Denmark; Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark; Correspondence: Address correspondence to: Lone Larsen, MD, PhD, Department of Gastroenterology and Hepatology, National Center of Excellence for Molecular Prediction of Inflammatory Bowel Disease (PREDICT), Aalborg University Hospital, Hobrovej 18, Aalborg 9000, Denmark.

K.D. Olsen

Department of Clinical Medicine, Center for Molecular Prediction of Inflammatory Bowel Disease (PREDICT), Aalborg University, Copenhagen, Denmark

H.S. Christensen

Department of Clinical Medicine, Center for Molecular Prediction of Inflammatory Bowel Disease (PREDICT), Aalborg University, Copenhagen, Denmark

K.H. Allin

Department of Clinical Medicine, Center for Molecular Prediction of Inflammatory Bowel Disease (PREDICT), Aalborg University, Copenhagen, Denmark; Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark

T. Jess

Department of Clinical Medicine, Center for Molecular Prediction of Inflammatory Bowel Disease (PREDICT), Aalborg University, Copenhagen, Denmark; Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark